Skip to main content
. Author manuscript; available in PMC: 2008 Oct 10.
Published in final edited form as: Vaccine. 2007 Aug 6;25(41):7247–7260. doi: 10.1016/j.vaccine.2007.07.038

Table 1.

Bacterial strains used in this study

Strain Description Source or ref.
E. coli    
     BL21 (DE3) F- ompT hsdSB (rB−mB−) gal dcm (DE3) Novagen
     C41 (DE3) F- ompT hsdSB (rBB−mB−) gal dcm (DE3) uncharacterized derivative of BL21 (DE3) Avidis
     TOP 10 F− mcrA Δ(mrr-hsdRMS-mcrBC)Φ80lacZΔM15 ΔlacX74 recA1 araD139Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG Invitrogen
     NovaBlue endA1 hsdR17 (rk12−mk12+) supE44 thi-1 recA1 gyrA96 relA1 lac [F’ proA+B+lacIq ZΔM15∷Tn10 (Tcr)] Novagen
     HB101 supE44 hsdS20 (rB−mB−) recA13 ara-14 proA2 lacY1 gaIK2 rpsL20 xyl-5 mtl-1 [51]
     
N. gonorrhoeae    
     MCV601 Lbp−[lbpB∷Ω (Strr)], derivative of FA19 [52]
     MCV602 TbpA− Lbp− [tbpA∷mTn3(CMr)lbpB∷Ω(Strr)], derivative of FA19 [52]
     FA19 Wild-type strain; serovar PorB1A-1 [53]
     MS11 Wild-type strain; serovar PorB1B-9 [54]
     FA1090 Wild-type strain; serovar PorB1B-3 [55]
     UU1008 Wild-type strain [13]
     Pgh3-2 Wild-type strain [13]
     4102 Wild-type strain [13]
     4121 Wild-type strain [13]
     4125 Wild-type strain [13]
     4141 Wild-type strain [13]
     4146 Wild-type strain [13]
     4178 Wild-type strain [13]
     4196 Wild-type strain [13]
     4134 Wild-type strain [13]